Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Huizhou Jinghao Medical Technology Co OCF Margin %?
Huizhou Jinghao Medical Technology CoBJSE:920925 60 OCF Margin % is 23.31% as of Jun. 2026, which is 76% above its 10-year median of 13.23. GuruFocus rates BJSE:920925 with a GF Score™ of 60/100 and a GF Value™ of ¥18.93 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Huizhou Jinghao Medical Technology Co ranks worse than 53.51% on this metric.
BJSE:920925'
s OCF Margin % Range Over the Past 10 Years
Min: -3.92 Med: 13.23 Max: 21.84
Current: 4.59
During the past 10 years, the highest OCF Margin % of Huizhou Jinghao Medical Technology Co was 21.84%. The lowest was -3.92%. And the median was 13.23%.
BJSE:920925's OCF Margin % is ranked worse than 53.51% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.64
vs BJSE:920925: 4.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co OCF Margin % Chart
BJSE:920925 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Huizhou Jinghao Medical Technology Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huizhou Jinghao Medical Technology Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Huizhou Jinghao Medical Technology Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Huizhou Jinghao Medical Technology Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co (BJSE:920925) has a OCF Margin % of 23.31% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. This is 76% above median its historical median of 13.23. According to the industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #435 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 53.5%.
Is Huizhou Jinghao Medical Technology Co's OCF Margin % too high?
Huizhou Jinghao Medical Technology Co's current OCF Margin % of 23.31% is 76% above median its 10-year median of 13.23. The Medical Devices & Instruments industry median OCF Margin % is 6.64. Huizhou Jinghao Medical Technology Co's value of 23.31% is 251.1% above this industry median. Based on the distribution chart, Huizhou Jinghao Medical Technology Co ranks #435 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Huizhou Jinghao Medical Technology Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Huizhou Jinghao Medical Technology Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #435 out of 813 companies for OCF Margin %. This places Huizhou Jinghao Medical Technology Co in the lower half of its industry. The industry median OCF Margin % is 6.64. Huizhou Jinghao Medical Technology Co's value of 23.31% is 251.1% above this benchmark. While the company's 10-year median is 13.23 vs. the industry median of 6.64, Huizhou Jinghao Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.64, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huizhou Jinghao Medical Technology Co's current OCF Margin % of 23.31% is 251.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huizhou Jinghao Medical Technology Co's current OCF Margin % is 23.31%, which is 76% above median its own 10-year median of 13.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huizhou Jinghao Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co (BJSE:920925) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.93, compared to a current price of ¥12.13 — trading 35.9% below its estimated fair value. The current OCF Margin % is 23.31%, which is 76% above median its 10-year median of 13.23 and 251.1% above the Medical Devices & Instruments industry median of 6.64. Huizhou Jinghao Medical Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Huizhou Jinghao Medical Technology Co (BJSE:920925), the current OCF Margin % is 23.31% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huizhou Jinghao Medical Technology Co (BJSE:920925) Overvalued in 2026?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co stock appears to be undervalued.
The current stock price of ¥12.13 is trading 35.9% below its estimated GF Value™ of ¥18.93.
GuruFocus considers Huizhou Jinghao Medical Technology Co to be Possible Value Trap.
Key valuation signals for BJSE:920925:
OCF Margin %: 23.31% (76% above median its 10-year median of 13.23)
GF Value™: ¥18.93 vs. price of ¥12.13 (35.9% below fair value)
Industry Position: 251.1% above the Medical Devices & Instruments median (#435 of 813)
No single metric tells the full story. See the BJSE:920925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920925 has been successfully added to your 
